Decoy Therapeutics (FP11) Ownership - Who Owns Decoy Therapeutics?
Decoy Therapeutics (FP11) Ownership Overview
- 2.88% Insiders
- 0.51% Mutual Funds
- 0.17% ETFs
- 96.44% Public Companies and Individual Investors
The ownership structure of Decoy Therapeutics (DE:FP11) stock is a mix of institutional, retail, and individual investors. Approximately 0.68% of the company’s stock is owned by Institutional Investors, 2.88% is owned by Insiders, and 96.44% is owned by Public Companies and Individual Investors.
The ownership structure of Decoy Therapeutics (DE:FP11) stock is a mix of institutional, retail, and individual investors. Approximately 0.68% of the company’s stock is owned by Institutional Investors, 2.88% is owned by Insiders, and 96.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jan 01, 2026 | Arnold Hanish | $17 | |
| Nov 23, 2025 | Arnold Hanish | $3,700 | |
| Nov 19, 2025 | Mark J. Rosenblum | $16,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Frederick Ii Pierce | 34,844 | Insider | 1.46% | 203,593 |
| Mark J. Rosenblum | 11,363 | Insider | 0.48% | 66,394 |
| Fidelity Concord Street Trust | 8,091 | Institution | 0.34% | 47,276 |
| Barbara Louise Hibner | 4,216 | Insider | 0.18% | 24,634 |
| Vanguard | 4,034 | Institution | 0.17% | 23,571 |
| Vanguard Index Funds | 4,034 | Institution | 0.17% | 23,571 |
| Peter Klaus Marschel | 3,900 | Insider | 0.16% | 22,788 |
| Arnold Hanish | 3,418 | Insider | 0.14% | 19,971 |
| William Mcvicar | 3,002 | Insider | 0.13% | 17,541 |
| Jonathan Lieber | 2,002 | Insider | 0.08% | 11,698 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 8,091 | Institution | 0.34% | 47,276 |
| Vanguard Index Funds | 4,034 | Institution | 0.17% | 23,571 |
FAQ
Who Owns Decoy Therapeutics (DE:FP11)?
According to the latest TipRanks data, approximately 0.68% of the company's stock is held by institutional investors, 2.88% is held by insiders, and 96.44% is held by public companies and individual investors.
What percentage of Decoy Therapeutics (DE:FP11) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.68% of Decoy Therapeutics (DE:FP11) stock is held by institutional investors: 0.51% by mutual funds and 0.17% by ETFs.
What percentage of Decoy Therapeutics (DE:FP11) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.44% of Decoy Therapeutics (DE:FP11) stock is held by public companies and individual investors.
Who owns the most shares of Decoy Therapeutics (DE:FP11)?
FREDERICK II PIERCE owns the most shares of Decoy Therapeutics (DE:FP11).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
